You are here

Clinical Trials: Heart Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, October 20, 2016 - 19:00
Conditions:   Foramen Ovale, Patent;   Heart Septal Defects, Atrial;   Atrial Septal Defect
Intervention:   Other: Blood samples
Sponsor:   University Hospitals of North Midlands NHS Trust
Recruiting - verified November 2016
Posted: Wednesday, October 19, 2016 - 19:00
Condition:   Acute Coronary Syndrome
Interventions:   Drug: Atorvastatin;   Other: Blood samples
Sponsor:   University Hospitals of North Midlands NHS Trust
Recruiting - verified November 2016
Posted: Monday, October 3, 2016 - 19:00
Condition:   Heart Failure With Normal Ejection Fraction
Interventions:   Biological: Cell Therapy;   Biological: Control Procedure
Sponsor:   University Medical Centre Ljubljana
Recruiting - verified October 2016
Posted: Wednesday, August 31, 2016 - 19:00
Condition:   Coronary Artery Disease
Interventions:   Drug: ticagrelor;   Drug: clopidogrel
Sponsor:   First Affiliated Hospital of Harbin Medical University
Recruiting - verified August 2016
Posted: Wednesday, August 10, 2016 - 19:00
Conditions:   Congestive Heart Failure;   Heart Failure, Diastolic
Interventions:   Biological: Allogenic Derived Cells;   Biological: Placebo/Control Arm
Sponsor:   Medical University of South Carolina
Recruiting - verified August 2016
Posted: Sunday, August 7, 2016 - 19:00
Condition:   Coronary Artery Disease
Intervention:   Biological: Transepicardial with Transseptal CD 133+ Implantation
Sponsor:   National Cardiovascular Center Harapan Kita Hospital Indonesia
Recruiting - verified August 2016
Posted: Friday, June 17, 2016 - 19:00
Condition:   Chronic Ischemic Heart Disease
Intervention:   Drug: Bone Marrow Derived Autologous CD133+ Selected Cell Product
Sponsor:   Michael Sekela
Recruiting - verified February 2017
Posted: Thursday, May 19, 2016 - 19:00
Conditions:   Hypoplastic Left Heart Syndrome;   Single Ventricle
Intervention:   Genetic: Autologous cardiac stem cells (JRM-001)
Sponsor:   Japan Regenerative Medicine Co., Ltd.
Not yet recruiting - verified May 2016
Posted: Wednesday, March 16, 2016 - 19:00
Conditions:   Stable Angina;   Unstable Angina;   STEMI;   NSTEMI;   Coronary Disease
Interventions:   Device: COMBO-Stent;   Drug: Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran;   Device: Any drug eluting stent oder bare metal sent;   Drug: ASA, Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran
Sponsors:   IHF GmbH - Institut für Herzinfarktforschung;   OrbusNeich
Not yet recruiting - verified March 2016
Posted: Monday, February 1, 2016 - 20:00
Condition:   Heart Failure
Intervention:   Biological: CSCC_ASC
Sponsors:   JKastrup;   European Union
Not yet recruiting - verified February 2016

Pages